Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Anika Therapeutics (ANIK) Change in Accured Expenses (2016 - 2026)

Anika Therapeutics has reported Change in Accured Expenses over the past 17 years, most recently at -$1.3 million for Q1 2026.

  • Quarterly Change in Accured Expenses rose 56.64% to -$1.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $249000.0 through Mar 2026, up 106.83% year-over-year, with the annual reading at -$1.5 million for FY2025, 59.12% up from the prior year.
  • Change in Accured Expenses was -$1.3 million for Q1 2026 at Anika Therapeutics, down from $141000.0 in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $4.6 million in Q3 2023 and troughed at -$4.3 million in Q2 2023.
  • The 5-year median for Change in Accured Expenses is -$558000.0 (2022), against an average of -$311941.2.
  • Year-over-year, Change in Accured Expenses soared 255.3% in 2023 and then crashed 567.67% in 2024.
  • A 5-year view of Change in Accured Expenses shows it stood at -$558000.0 in 2022, then soared by 231.54% to $734000.0 in 2023, then crashed by 227.38% to -$935000.0 in 2024, then skyrocketed by 115.08% to $141000.0 in 2025, then plummeted by 1049.65% to -$1.3 million in 2026.
  • Per Business Quant, the three most recent readings for ANIK's Change in Accured Expenses are -$1.3 million (Q1 2026), $141000.0 (Q4 2025), and $3.6 million (Q3 2025).